Clinical Trials Directory

Trials / Completed

CompletedNCT06261216

Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the association between increased lifetime physical activity and the development of wild-type transthyretin amyloid cardiomyopathy.

Detailed description

Transthyretin amyloidosis is considered to be the most common cause of cardiac amyloidosis, with an increasing diagnosis rate over the last decade. Though once considered to be a rare disease, recent data suggest it is underappreciated as a common cause of cardiac diseases and syndromes such as left ventricular hypertrophy, aortic stenosis, and heart failure with preserved ejection fraction, especially in the elderly. Wild-type transthyretin amyloidosis, which is associated with ageing, is currently considered to be the most frequent form of amyloidosis worldwide, and is dominated by cardiac symptoms. Other than male gender and advanced age, risk factors for the development of wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) are largely unknown. There is rising empirical observation that patients with wtATTR-CM frequently have a substantial history of athletic activity, which might contribute to the manifestation of the disease. This study aims to create evidence of a correlation between increased lifetime physical activity and the development of wtATTR-CM. Furthermore, the investigators aim to explore the association between certain sport disciplines and disease development.

Conditions

Interventions

TypeNameDescription
OTHERInterview* International Physical Activity Questionnaire (IPAQ-SF) * interviewer-administered modified Lifetime Total Physical Activity Questionnaire (LTPAQ) form

Timeline

Start date
2024-02-16
Primary completion
2025-11-20
Completion
2025-11-20
First posted
2024-02-15
Last updated
2026-04-09

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT06261216. Inclusion in this directory is not an endorsement.